Korhonen O - Search Results

1

Detecting different amorphous - Amorphous phase separation patterns in co-amorphous mixtures with high resolution imaging FTIR spectroscopy.

Kilpeläinen T, Ervasti T, Uurasjärvi E, Koistinen A, Ketolainen J, Korhonen O, Pajula K. Kilpeläinen T, et al. Among authors: korhonen o. Eur J Pharm Biopharm. 2022 Nov;180:161-169. doi: 10.1016/j.ejpb.2022.09.011. Epub 2022 Sep 17. Eur J Pharm Biopharm. 2022. PMID: 36122786 Free article.

2

Deformation behaviors of tolbutamide, hydroxypropyl-beta-cyclodextrin, and their dispersions.

Suihko E, Poso A, Korhonen O, Gynther J, Ketolainen J, Paronen P. Suihko E, et al. Among authors: korhonen o. Pharm Res. 2000 Aug;17(8):942-8. doi: 10.1023/a:1007523103979. Pharm Res. 2000. PMID: 11028939

3

Complexation with tolbutamide modifies the physicochemical and tableting properties of hydroxypropyl-beta-cyclodextrin.

Suihko E, Korhonen O, Järvinen T, Ketolainen J, Jarho P, Laine E, Paronen P. Suihko E, et al. Among authors: korhonen o. Int J Pharm. 2001 Mar 14;215(1-2):137-45. doi: 10.1016/s0378-5173(00)00682-7. Int J Pharm. 2001. PMID: 11250099

4

Effects of physical properties for starch acetate powders on tableting.

Korhonen O, Pohja S, Peltonen S, Suihko E, Vidgren M, Paronen P, Ketolainen J. Korhonen O, et al. AAPS PharmSciTech. 2002;3(4):E34. doi: 10.1208/pt030434. AAPS PharmSciTech. 2002. PMID: 12916928 Free PMC article.

5

Evaluation of novel starch acetate-diltiazem controlled release tablets in healthy human volunteers.

Korhonen O, Kanerva H, Vidgren M, Urtti A, Ketolainen J. Korhonen O, et al. J Control Release. 2004 Mar 24;95(3):515-20. doi: 10.1016/j.jconrel.2003.12.026. J Control Release. 2004. PMID: 15023462 Clinical Trial.

6

Prediction of contact angle for pharmaceutical solids from their molecular structure.

Suihko E, Forbes RT, Korhonen O, Ketolainen J, Paronen P, Gynther J, Poso A. Suihko E, et al. Among authors: korhonen o. J Pharm Sci. 2005 Apr;94(4):745-58. doi: 10.1002/jps.20306. J Pharm Sci. 2005. PMID: 15682381

7

Partial least square projections to latent structures analysis (PLS) in evaluating and predicting drug release from starch acetate matrix tablets.

Korhonen O, Matero S, Poso A, Ketolainen J. Korhonen O, et al. J Pharm Sci. 2005 Dec;94(12):2716-30. doi: 10.1002/jps.20485. J Pharm Sci. 2005. PMID: 16258997

8

Controlled release of saccharides from matrix tablets.

Mäki R, Suihko E, Korhonen O, Pitkänen H, Niemi R, Lehtonen M, Ketolainen J. Mäki R, et al. Among authors: korhonen o. Eur J Pharm Biopharm. 2006 Feb;62(2):163-70. doi: 10.1016/j.ejpb.2005.07.009. Epub 2005 Dec 15. Eur J Pharm Biopharm. 2006. PMID: 16343875

9

Liquid boundary movements in cylindrical and convex hydrophobic matrix tablets: Effects on tablet cracking and drug release.

Pajander J, van Veen B, Korhonen O, Lappalainen R, Ketolainen J. Pajander J, et al. Among authors: korhonen o. Eur J Pharm Biopharm. 2006 Oct;64(2):167-72. doi: 10.1016/j.ejpb.2006.05.011. Epub 2006 Jun 2. Eur J Pharm Biopharm. 2006. PMID: 16846722

10

Predicting the drug concentration in starch acetate matrix tablets from ATR-FTIR spectra using multi-way methods.

Matero S, Pajander J, Soikkeli AM, Reinikainen SP, Lahtela-Kakkonen M, Korhonen O, Ketolainen J, Poso A. Matero S, et al. Among authors: korhonen o. Anal Chim Acta. 2007 Jul 9;595(1-2):190-7. doi: 10.1016/j.aca.2007.02.008. Epub 2007 Feb 12. Anal Chim Acta. 2007. PMID: 17606000

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters